HRP20000545A2 - E-2-/4-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy/ethanol and pharmaceutical compositions thereof - Google Patents

E-2-/4-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy/ethanol and pharmaceutical compositions thereof

Info

Publication number
HRP20000545A2
HRP20000545A2 HR20000545A HRP20000545A HRP20000545A2 HR P20000545 A2 HRP20000545 A2 HR P20000545A2 HR 20000545 A HR20000545 A HR 20000545A HR P20000545 A HRP20000545 A HR P20000545A HR P20000545 A2 HRP20000545 A2 HR P20000545A2
Authority
HR
Croatia
Prior art keywords
enyl
phenoxy
diphenyl
chloro
ethanol
Prior art date
Application number
HR20000545A
Other languages
English (en)
Inventor
Marja-Liisa Soedervall
Arja Kalapudas
Antti Viitanen
Eero Mantylae
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of HRP20000545A2 publication Critical patent/HRP20000545A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20000545A 1998-02-19 2000-08-18 E-2-/4-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy/ethanol and pharmaceutical compositions thereof HRP20000545A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9803521.5A GB9803521D0 (en) 1998-02-19 1998-02-19 New compounds and pharmaceutical compositions thereof
PCT/FI1999/000137 WO1999042427A1 (en) 1998-02-19 1999-02-19 E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
HRP20000545A2 true HRP20000545A2 (en) 2001-02-28

Family

ID=10827263

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000545A HRP20000545A2 (en) 1998-02-19 2000-08-18 E-2-/4-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy/ethanol and pharmaceutical compositions thereof

Country Status (33)

Country Link
US (1) US6395785B1 (es)
EP (1) EP1056701B1 (es)
JP (1) JP2002503713A (es)
KR (1) KR100755918B1 (es)
CN (1) CN1161314C (es)
AR (1) AR014961A1 (es)
AT (1) ATE252531T1 (es)
AU (1) AU755798B2 (es)
BG (1) BG64471B1 (es)
BR (1) BR9907688A (es)
CA (1) CA2321122C (es)
CZ (1) CZ294315B6 (es)
DE (1) DE69912247T2 (es)
DK (1) DK1056701T3 (es)
EA (1) EA002919B1 (es)
EE (1) EE04233B1 (es)
ES (1) ES2211038T3 (es)
GB (1) GB9803521D0 (es)
GE (1) GEP20022794B (es)
HR (1) HRP20000545A2 (es)
HU (1) HUP0101354A3 (es)
ID (1) ID26857A (es)
IL (1) IL137214A (es)
NO (1) NO325595B1 (es)
NZ (1) NZ505637A (es)
PL (1) PL193315B1 (es)
PT (1) PT1056701E (es)
RS (1) RS49660B (es)
SK (1) SK285940B6 (es)
TR (1) TR200002037T2 (es)
UA (1) UA57132C2 (es)
WO (1) WO1999042427A1 (es)
ZA (1) ZA991232B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW593256B (en) * 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
SI1235776T1 (sl) * 1999-11-16 2006-06-30 Hormos Medical Corp Trifenilalkenski derivati in njihova uporaba kot selektivni estrogenski receptorski modulatorji
US20040248989A1 (en) 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
CN101448490A (zh) 2006-05-22 2009-06-03 霍尔莫斯医疗有限公司 治疗慢性非细菌性前列腺炎的选择性雌激素受体调节剂或者芳香酶抑制剂
EP2121553B1 (en) 2007-02-14 2012-06-27 Hormos Medical Ltd. Method for the preparation of therapeutically valuable triphenylbutene derivatives
US7504530B2 (en) 2007-02-14 2009-03-17 Hormos Medical Ltd. Methods for the preparation of fispemifene from ospemifene
CN102770402B (zh) 2010-01-19 2016-01-20 坎布雷卡尔斯库加公司 制造二苯甲酮衍生物的新方法
JP6174156B2 (ja) 2012-10-19 2017-08-02 フェルミオン オサケ ユキチュア オスペミフェンの製造方法
US20150321983A1 (en) * 2012-10-19 2015-11-12 Fermion Oy A process for the preparation of ospemifene
CN104030896A (zh) * 2013-03-07 2014-09-10 天津药物研究院 一种简易去除欧司哌米芬特异杂质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2126576B (en) 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
GB9418067D0 (en) 1994-09-07 1994-10-26 Orion Yhtymae Oy Triphenylethylenes for the prevention and treatment of osteoporosis
GB9604577D0 (en) * 1996-03-04 1996-05-01 Orion Yhtymae Oy Serum cholesterol lowering agent

Also Published As

Publication number Publication date
SK285940B6 (sk) 2007-11-02
BG104713A (en) 2001-03-30
YU51000A (sh) 2002-11-15
PL193315B1 (pl) 2007-01-31
IL137214A0 (en) 2001-07-24
US6395785B1 (en) 2002-05-28
CA2321122A1 (en) 1999-08-26
DE69912247T2 (de) 2004-07-29
CZ294315B6 (cs) 2004-11-10
EP1056701A1 (en) 2000-12-06
EE04233B1 (et) 2004-02-16
BG64471B1 (bg) 2005-04-30
ZA991232B (en) 1999-09-17
JP2002503713A (ja) 2002-02-05
UA57132C2 (uk) 2003-06-16
HUP0101354A3 (en) 2002-05-28
PL342445A1 (en) 2001-06-04
ATE252531T1 (de) 2003-11-15
KR20010040985A (ko) 2001-05-15
TR200002037T2 (tr) 2001-02-21
EP1056701B1 (en) 2003-10-22
NZ505637A (en) 2002-10-25
NO20003987D0 (no) 2000-08-07
CN1161314C (zh) 2004-08-11
AR014961A1 (es) 2001-04-11
ES2211038T3 (es) 2004-07-01
PT1056701E (pt) 2004-03-31
GB9803521D0 (en) 1998-04-15
WO1999042427A1 (en) 1999-08-26
KR100755918B1 (ko) 2007-09-06
GEP20022794B (en) 2002-09-25
CZ20002927A3 (cs) 2000-12-13
DE69912247D1 (de) 2003-11-27
CA2321122C (en) 2008-02-12
IL137214A (en) 2005-05-17
NO325595B1 (no) 2008-06-23
EA200000851A1 (ru) 2001-02-26
SK12052000A3 (sk) 2001-01-18
BR9907688A (pt) 2000-11-14
AU2524499A (en) 1999-09-06
HUP0101354A2 (hu) 2002-03-28
EA002919B1 (ru) 2002-10-31
RS49660B (sr) 2007-09-21
AU755798B2 (en) 2002-12-19
CN1291178A (zh) 2001-04-11
EE200000473A (et) 2001-12-17
ID26857A (id) 2001-02-15
DK1056701T3 (da) 2004-02-02
NO20003987L (no) 2000-08-07

Similar Documents

Publication Publication Date Title
ZA200204147B (en) Aerosol composition comprising formoterol.
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
AU7429500A (en) Piperidine quinolyl propyl derivatives, preparation method and compositions containing same
HUP0001539A3 (en) 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
IL133293A0 (en) Pharmaceutical compositions comprising cyclodextrins
IL138568A0 (en) 1-[(1-substituted-4-piperidinyl) methyl] -4- piperidine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
AU2557800A (en) Preservative compounds and compositions
IL123013A (en) Substituted imidazoles having biphenylsulfonyl substitution, and pharmaceutical compositions comprising them
HUP0203505A3 (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, and pharmaceutical compositions containing said compounds
AU7380700A (en) Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions
AU2001235737A1 (en) Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
AU5565099A (en) Pharmaceutical compositions and methods for use
ZA200005510B (en) Pharmaceutical composition.
ZA9710272B (en) Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds.
HRP20000545A2 (en) E-2-/4-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy/ethanol and pharmaceutical compositions thereof
IL144895A0 (en) Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds
EP1138643A3 (en) Binder for hydraulic compositions, and hydraulic compositions containing the same
EP1249482A4 (en) AEROSOL COMPOSITION
IL125244A0 (en) Pharmaceutical compositions containing low-melting waxes
HUP9902465A3 (en) New amidinium derivatives, pharmaceutical compositions containing same, and uses thereof
AU7816000A (en) Pediculocidal and veterinary compositions
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU5176299A (en) Compound, composition and use
HK1044117A1 (en) Pharmaceutical composition.
ZA99890B (en) Pharmaceutical compositions.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODBC Application rejected